- Novo Nordisk suspended from ABPI for two years over 'serious breaches' of code of practice.
- Complaint alleged Novo Nordisk sponsored courses on weight management for health professionals without disclosing involvement.
- ABPI panel concluded Novo Nordisk's funding for training was linked to promotion of its drug Saxenda.
- Novo Nordisk to undergo audits in 2023 and 2024 to show sustained improvement for ABPI board to consider reinstating membership.
Novo Nordisk suspended from UK lobby group
Danish drugmaker Novo Nordisk has been suspended from the Association of the British Pharmaceutical Industry (ABPI) for two years over what the ABPI on Thursday described as "serious breaches" of its code of practice.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QS2HKPIG5VJDPCACOJA74BEON4.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UQPIK3T2DVOX7EIO4QZCM5HIAA.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZJM34EMBWJO7BKLC32OVFVZECQ.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/75ZPE5KGUZKI7JLZHA3YCDVDVA.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/VAKMASTY6JJC5EBSX4MM5OEQKM.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/RCWZE2OK3BNCJNRVFOS74NYF7M.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/6W5WJY7T4NLKVFJO5JX37LPYS4.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BYL7ESQPMFMSNNVJSVCYKYTPH4.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/OGBROYPEZVMVNLCKMBDIE2XJCE.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/JG3AL7UAGVPBJHJUNQS4YZL4SE.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QS2HKPIG5VJDPCACOJA74BEON4.jpg&description=Novo%20Nordisk%20suspended%20from%20UK%20lobby%20group){kind=link}